MIFTEC and US Nuclear Join the Race to Fill $7 Billion/Year Shortage of Medical Isotopes

US Nuclear Corp (OTCBB: UCLE) and MIFTEC recently signed a definitive agreement which formally appoints US Nuclear as the exclusive manufacturer of MIFTEC’s revolutionary medical isotope generators for North America and Asia, and makes US Nuclear a sales representative for all MIFTEC products.  This definitive agreement replaces the Letter of Intent signed back in December 2017.  MIFTEC’s parent company, MIFTI Nuclear Fusion, is a leader in developing fusion power and has shown that their staged Z-pinch fusion technique produces high neutron flux which can be used to produce medical isotopes at a fraction of the cost of current methods.

To read more please visit: https://globenewswire.com/news-release/2018/06/05/1516948/0/en/MIFTEC-and-US-Nuclear-Join-the-Race-to-Fill-7-Billion-Year-Shortage-of-Medical-Isotopes.html

Source: GlobeNewswire

​